CSIMarket
 


Autolus Therapeutics Plc  (AUTL)
Other Ticker:  
 

Cumulative Autolus Therapeutics Plc's Leverage Ratio for Trailing Twelve Months Period

AUTL's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

AUTL Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
Y / Y Equity Growth -39.56 % -4.67 % -4.67 % -4.67 % -4.67 %
Y / Y Total Liabilities Growth 17.97 % 112.52 % 112.52 % 112.52 % 112.52 %
Leverage Ratio for Trailing Twelve Months Period 0.72 0.62 0.54 0.45 0.36
Total Ranking # 1360 # # # 1581 # 1365
Seq. Equity Growth -39.56 % 0 % 0 % 0 % -4.67 %
Seq. Total Liabilities Growth 17.97 % 0 % 0 % 0 % 112.52 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to net new borrowings of 17.97%, Leverage Ratio for Trailing Twelve Months Period improved to 0.72, above Autolus Therapeutics Plc's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 110 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Autolus Therapeutics Plc. While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are AUTL's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 111
Sector # 644
S&P 500 # 2008


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.74 0.45 0.29
(Sep 30 2023)   (Dec 31 2021)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Axcella Health Inc   1.98 
Valneva Se  1.95 
Armata Pharmaceuticals Inc   1.77 
Aceragen Inc   1.68 
Windtree Therapeutics Inc  1.68 
Gilead Sciences Inc   1.67 
Evaxion Biotech A  1.65 
Allena Pharmaceuticals Inc.  1.52 
Atara Biotherapeutics Inc   1.51 
Cannabis Global Inc.  1.50 
Champions Oncology Inc   1.48 
Avalon Globocare Corp   1.37 
Adma Biologics Inc   1.30 
X4 Pharmaceuticals Inc  1.28 
Codiak Biosciences Inc   1.26 
Meiragtx Holdings Plc  1.19 
Curis Inc   1.17 
Pluri Inc   1.16 
Humacyte Inc   1.16 
Poseida Therapeutics Inc   1.07 
Biocardia Inc  1.05 
Sutro Biopharma Inc   1.01 
Applied Genetic Technologies Corporation  1.01 
Biogen Inc   0.99 
Logicbio Therapeutics Inc   0.97 
Eiger Biopharmaceuticals Inc   0.93 
Innate Pharma Sa  0.93 
Biomx Inc   0.90 
Sangamo Therapeutics Inc   0.90 
Orchard Therapeutics Plc  0.82 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com